Search Results - "Demidov, Nikolay A."

Cardiovascular outcomes of dapagliflozin in type 2 diabetes mellitus in real clinical practice: a meta-analysis of observational studies by Antsiferov, Mikhail B., Demidov, Nikolay A.

“…Aim. To conduct a meta-analysis of population-based observational studies of dapagliflozin compared with therapy without iNGLT-2 to assess its effect on the…”
Get full text

Modern trends of blood glucose self-monitoring by Antsiferov, Mikhail B., Koteshkova, Olga M., Antsiferova, Daria M., Demidov, Nikolay A.

“…Objective. To consider modern means of monitoring glycemia using a mobile application that allows remote control of diabetes mellitus (DM). The main…”
Get full text

The dynamics of the main epidemiological indicators among living in Moscow patients with diabetes mellitus (2013–2018) by Antsiferov, Mikhail B., Demidov, Nikolay A., Kalashnikova, Marina F., Duhareva, Olga V., Vikulova, Olga K., Shestakova, Marina V.

“…BACKGROUND: State Register of Diabetes Mellitus (SRDM) plays an important role in the dynamic analysis of the epidemiological parameters that evaluate the…”
Get full text

Resolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy by Antsiferov, Mikhail B., Galstyan, Gagik R., Zilov, Alexey V., Mayorov, Alexander Y., Markova, Tatyana N., Demidov, Nikolay A., Koteshkova, Olga M., Laptev, Dmitry N., Vitebskaya, Alisa V.

“…The Scientific Advisory Board, chaired by Professor G. R. Galstyan (cochair - A.V. Zilov), met in Moscow on 19 June 2018 to discuss the possibilities of…”
Get full text

INFLUENCE OF TYPE 2 SODIUM-GLUCOSE CO-TRANSPORTER INHIBITORS (DAPAGLIFLOZIN) ON THE INDICATORS OF TOTAL MORTALITY IN PATIENTS WITH TYPE 2 DIABETES (CARDIA-MOS STUDY, MOSCOW) by Mikhail B. Antsiferov, Nikolay A. Demidov, Maria A. Balberova, Olga V. Lobanova, Irina G. Mudrikova, Dinara G. Gusenbekova

“…BACKGROUND: Widespread clinical use of drugs with cardioprotective/nephroprotective properties – particularly sodium-glucose cotransporter type 2 inhibitors…”
Get full text

Impact of dapagliflozin on life expectancy in type 2 diabetes mellitus patients in routine practice by Antsiferov, M. B., Demidov, N. A., Tabakaev, N. A.

“…BACKGROUND : Value of diabetes mellitus as social and medical issue seems to be growing worldwide. High rates of concomitant cardiovascular disease represent…”
Get full text

Pharmacoepidemiological analysis of type 1 diabetes mellitus insulin therapy (According to the Moscow segment of the State Register of Diabetes Mellitus) by Antsiferov, M. B., Kantemirova, M. A., Demidov, N. A., Kalashnikova, M. F.

“…BACKGROUND : When developing programs for state reimbursement of the cost of medical services and medicines, when providing assistance to patients suffering…”
Get full text

Influence of type 2 sodium-glucose co-transporter inhibitors (dapagliflozin) on the indicators of total mortality in patients with type 2 diabetes (CARDIA-MOS study, Moscow) by Antsiferov, M. B., Demidov, N. A., Balberova, M. A., Lobanova, O. V., Mudrikova, I. G., Gusenbekova, D. G.

“…BACKGROUND: The widespread use in clinical practice of drugs with cardio- and nephroprotective properties, in particular, sodium-glucose cotransporter type 2…”
Get full text

Real World Effectiveness of fixed combination of glargine 100 U/ml and lixisenatide therapy in outpatients with Type 2 Diabetes: A Retrospective Cohort Study SOLO by Antsiferov, M. B., Demidov, N. A., Balberova, M. A., Safronova, T. I., Mishra, O. A., Magomedova, S. G.

“…Background: The effectiveness and safety of a fixed combination of insulin glargine 100 ME/ml and lixisenatide for treatment of patients with type 2 diabetes…”
Get full text

Results of a clinical trial of the efficacy and safety of vildagliptin and metformin fixed combination in real clinical practice in Russia (MASTER study) by Demidov, N. A., Antsiferov, M. B., Zilov, A. V.

“…BACKGRAUND : The widespread prevalence of type 2 diabetes mellitus (T2DM), high mortality and disability of such patients are the reason for the constant…”
Get full text

Endocrine aspect of overtraining in athletes by Z. G. Ordzhonikidze, N. A. Demidov, V. I. Pavlov, V. A. Badtieva, A. S. Rezepov, O. S. Volkova, S. G. Plotnikov, M. V. Gvinianidze

“…Striving to achieve the goals of the training process with the irrational use of physical activity can lead to a decrease in the adaptive and reserve…”
Get full text

Russian Hydrogen Masers For Ground And Space Applications by Belyaev, Alexandr A., Demidov, Nikolay A., Medvedev, Sergey Y., Pavlenko, Yuri K., Sakharov, Boris A., Vorontsov, Vladislav G.

“…Active and passive hydrogen masers developed and manufactured by Russian company "Vremya-CH" are widely used over the world in scientific laboratories, radio…”
Get full text